Feasibility of Chemoradiotherapy for Oesophageal Cancer in Elderly Patients Aged ≥75 Years: A Prospective, Single-Arm Phase II Study

Author： Servagi-Vernat Stephanie  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.26, Iss.3, 2009-01, pp. : 255-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma

By Furman Wayne  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1660-1670

Springer Publishing Company

Access to resources Recommend Favorite

Antihypertensive Treatment in Elderly Patients Aged 75 Years or Over: A 24-Week Study of the Tolerability of Candesartan Cilexetil in Relation to Hydrochlorothiazide

By Neldam S.  

Drugs & Aging, Vol. 18, Iss. 3, 2001-03 ,pp. : 225-232

Adis International

Access to resources Recommend Favorite

An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

By Stadler Walter M.   Vaughn David J.   Sonpavde Guru   Vogelzang Nicholas J.   Tagawa Scott T.   Petrylak Daniel P.   Rosen Peter   Lin Chia-Chi   Mahoney John   Modi Sanjiv   Lee Peter   Ernstoff Marc S.   Su Wu-Chou   Spira Alexander   Pilz Korinna   Vinisko Richard   Schloss Charles   Fritsch Holger   Zhao Charles   Carducci Michael A.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 976-982

Blackwell Publishing

Access to resources Recommend Favorite

Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil/Hydrochlorothiazide-Based Treatment Algorithm in Elderly Patients (Age ≥65 Years) Stratified by Age, Sex and Race: Subgroup Analysis of a 12-Week, Open-Label, Single-Arm, Dose-Titration Study

By Neutel Joel  

Drugs & Aging, Vol. 28, Iss. 6, 2011-06 ,pp. : 477-490

Adis International

Access to resources Recommend Favorite

A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

By Garcia Jorge A.   Hudes Gary R.   Choueiri Toni K.   Stadler Walter M.   Wood Laura S.   Gurtler Jayne   Bhatia Shailender   Joshi Adarsh   Hozak Rebecca R.   Xu Yihuan   Schwartz Jonathan D.   Thompson John A.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1647-1655

Blackwell Publishing

Access to resources Recommend Favorite